CAR-T cell therapies are becoming established as an important treatment modality for cancer. Following the approval by the FDA in 2017, five additional CAR-T therapies have been approved.
Education
- PhD, management science, Belgium
- MBA, MIT Sloan School of Management
- MS, Belgium
Valery Panier is a core member of Boston Consulting Group’s Health Care practice. He joined the Boston office in 2000 and served as North America Leader of BCG's health care business from 2018 to 2023. Prior to that, he led BCG's biopharmaceutical R&D topic globally.
Val has extensive experience in biopharma strategy, operations, and organization-related topics, and has supported biotech and biopharma companies globally on many aspects of research and development. His primary areas of expertise include disease area strategy and portfolio review, clinical development optimization, R&D governance effectiveness, and innovation sourcing.
Prior to joining BCG, Val worked as a Research Scholar at the Massachusetts Institute of Technology where he developed performance monitoring systems.
